TRAF7 is altered in 1.41% of all cancers with lung adenocarcinoma, colon adenocarcinoma, breast invasive ductal carcinoma, cutaneous melanoma, and meningioma having the greatest prevalence of alterations .
The most common alterations in TRAF7 are TRAF7 Amplification (0.17%), TRAF7 Loss (0.07%), TRAF7 Fusion (0.21%), TRAF7 G536S (0.02%), and TRAF7 R641H (0.03%) .
2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.
3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.